Survival RateDisease-Free SurvivalSurvival AnalysisTreatment OutcomePrognosisNeoplasm StagingRetrospective StudiesKaplan-Meier EstimateAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyNeoplasm Recurrence, LocalFollow-Up StudiesChemotherapy, AdjuvantCell SurvivalProportional Hazards ModelsTime FactorsLiver NeoplasmsVincristineLymphatic MetastasisTumor Markers, BiologicalCisplatinMultivariate AnalysisRadiotherapy, AdjuvantLung NeoplasmsCyclophosphamideDoxorubicinFluorouracilSurvivalAntineoplastic AgentsAdenocarcinomaRadiotherapy DosageCarcinoma, Squamous CellRemission InductionNeoplasm MetastasisBreast NeoplasmsCarcinoma, HepatocellularDose FractionationPrednisoneChemoradiotherapyNeoadjuvant TherapyDrug Administration ScheduleRecurrenceSalvage TherapyDisease ProgressionEtoposideHepatectomyGraft SurvivalProspective StudiesImmunohistochemistryCarcinoma, Non-Small-Cell LungActuarial AnalysisRadiotherapyStomach NeoplasmsNasopharyngeal NeoplasmsRisk FactorsColorectal NeoplasmsCarcinomaEsophageal NeoplasmsSarcomaBrain NeoplasmsLymph Node ExcisionBrachytherapyDeoxycytidineVinblastineBone NeoplasmsNeoplasm InvasivenessMethotrexateInduction ChemotherapyHead and Neck NeoplasmsCohort StudiesAge FactorsChemoembolization, TherapeuticBleomycinPredictive Value of TestsLymphoma, Large B-Cell, DiffuseRadiotherapy, ConformalHodgkin DiseaseAntimetabolites, AntineoplasticLeucovorinOrganoplatinum CompoundsLymphoma, Non-HodgkinProcarbazineAntibodies, Monoclonal, Murine-DerivedRisk AssessmentTransplantation, AutologousCytarabineTreatment FailureCarboplatinRadiosurgeryDacarbazineNeoplasm GradingOvarian NeoplasmsHypopharyngeal NeoplasmsHematopoietic Stem Cell TransplantationRectal NeoplasmsPaclitaxelChemoradiotherapy, AdjuvantTransplantation, HomologousTaxoidsOsteosarcoma